Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
432,001,939
-
Total 13F shares
-
146,093,806
-
Share change
-
+146,093,806
-
Total reported value
-
$7,034,558,503
-
Put/Call ratio
-
59%
-
Price per share
-
$48.55
-
Number of holders
-
119
-
Value change
-
+$7,034,558,867
-
Number of buys
-
119
Institutional Holders of Royalty Pharma plc - Common Stock (RPRX) as of Q2 2020
As of 30 Jun 2020 Royalty Pharma plc - Common Stock (RPRX) had 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 146,093,806 shares of stock of the company.
Largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, HARVARD MANAGEMENT CO INC, Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, MORGAN STANLEY, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, JPMORGAN CHASE & CO, and VICTORY CAPITAL MANAGEMENT INC.
This table shows 119 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.